Gateway 2012: Hamilton Company - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2012: Hamilton Company


Hamilton Company
4970 Energy Way
Reno, NV 89502
Contact: Amber Ratcliff / Marketing Manager
Phone: 800-648-5950
URL: www.hamiltoncompany.com/Sensors

Company Description:

Hamilton Company is a global enterprise with manufacturing facilities in Reno, Nevada and Bonaduz, Switzerland. We are the worldwide leader in the design and manufacturing of manual, semi-automated, and robotic products for liquid handling as well as analytical detection. We offer a complete line of high quality pH, redox, conductivity, and oxygen electrodes for laboratory and process measurement. For over 50 years, we’ve been satisfying customers by combining quality materials with skilled workmanship, ensuring the highest level of performance to every device we manufacture. Hamilton’s lifelong commitment to accuracy and quality has earned us a global ISO 9001 certification.

INTERPHEX 2012 Booth Preview:

Hamilton Company manufactures application-oriented pH, ORP, dissolved oxygen, and conductivity sensors distinguished by their high quality, long life, and competitive price. Our intelligent VISIFERM optical dissolved oxygen probe offers technology that sets new standards in DO measurement. The new Hamilton ARC revolutionizes process analytics by replacing the traditional transmitter with a microprocessor within the sensor. ARC sensors measure more reliably as well as save on cost because they communicate directly with the process control system. Stop by our INTERPHEX 2012 booth # 3564 to discover more innovations from Hamilton.

Online PDF Documents:
Hamilton ARC Catalog
Hamilton Process Sensors Catalog

 

 



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here